The University of Texas MD Anderson Cancer Center – Professor, Department of Pediatrics Patient Care, Division of Pediatrics
Dr. Friedman’s primary interests are pediatric neuro-oncology and conducting pediatric brain tumor research. His overarching goal is to improve outcomes for children with malignant brain tumors by developing and improving novel, targeted therapeutics like oncolytic engineered herpes simplex virotherapy in the lab and then translating these therapies to clinical trials.
Dr. Friedman is a graduate of the College of William and Mary and the Medical College of Georgia. He completed his pediatric residency and fellowship in pediatric hematology/oncology at the University of Alabama at Birmingham.